Clearance Summary
MEDO-Thyroid received FDA 510(k) clearance under submission number K203502, sponsored by Medo DX Pte. , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2021-04-23.
- Submission: K203502
- Applicant / Sponsor: Medo DX Pte. , Ltd.
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.2050
- Decision date: 2021-04-23
Classification & Regulation
This clearance is catalogued under FDA product code QIH and 21 CFR 892.2050, within the Radiology review panel as a Class II device.